BioCentury serves as the hub of several biotechnology publications, including BioCentury, the Bernstein Report on BioBusiness, BioCentury Extra, SciBX: Science-Business eXchange, BioCentury Week in Review and BioCentury Quarterly Stock Roundup. All content is original and created in-house using information from primary sources. The publication DOES NOT accept anything written by outside contributors (ie. contributed articles, white papers, etc.). Send press releases to the pressreleases@biocentury.com and longer pitches directly to Editors. This outlet offers RSS (Really Simple Syndication).

Established in January 1993 and written for an international audience of senior company managers and members of the finance community. Supplies answers to important questions about corporate strategy, management decisions, partnering, emerging technology, clinical data and the financing markets that are key to understanding how value is created by biotechnology companies. Departments and sections include: Cover Story, Marketing, Strategy, Technology, Noteworthy, Emerging Company Profile, Regulation, Politics and Policy, Ebb and Flow, Online this week, Stock charts and tables and Company index. The newsletter notes the featured Online Links of the week, where subscribers can be informed of news that is available on the web. Has three main sections: the A section BioCentury, The Bernstein Report on BioBusiness, which provides analysis, interpretation and commentary on industry development, corporate performance, technology, public policy and shareholder value; and BioCentury II, which is a compendium of corporate, clinical and financial news, providing an efficient surveillance of deals, regulatory events, clinical reports and financing activity. This outlet offers RSS (Really Simple Syndication).

Published by BioCentury Publications and Nature Publishing Group, formerly known as SciBX. Covers biotechnology and the biotechnology industry with a focus on life sciences research with investment potential. Editorial queries, comments and press releases are welcome - these should be submitted via email. This outlet offers RSS (Really Simple Syndication).

Covers the biotechnology industry. Features performance data on more than 500 public biotech companies in the U.S., Europe and the Asia-Pacific. This outlet offers RSS (Really Simple Syndication).

Provides analysis, interpretation and commentary on biotechnology industry development, corporate performance and shareholder value to top managers and the institutional investment community. Includes reviews of business models and technology, analysis of clinical and product development, extensive reporting on the financial markets, and commentary on public policy and regulatory issues. Sent to readers as a PDF. This outlet offers RSS (Really Simple Syndication).

Provided for top managers and the institutional investment community involved in the biotechnology industry. Includes corporate, clinical and financial news, and provides updates on deals, regulatory events, clinical activities and financings. This outlet offers RSS (Really Simple Syndication).

Covers significant experimental results in the diverse fields of biological research. Topics covered include biochemistry, cell biology, developmental biology, immunology, neurobiology, biophysics, molecular biology and plant biology.

Provides a link between the sciences of biology, chemistry, and genetics by offering an interdisciplinary forum for the discussion of new developments. Includes original papers on fundamental experimental and theoretical research in the biochemical genetics of all organisms, from viruses to man. Contributions deal with the molecular aspects of genetic variation and evolution, mutation, gene action and regulation, immunogenetics, somatic cell genetics, and nucleic acid function in heredity and development, and with the biochemical aspects of genetic defects.

Written for pharmacologists, biochemists, virologists and toxicologists. Content covers research findings in pharmacology. The journal publishes the following types of reports: (1) Full-length Research Papers. These contain the results of original research on an issue of relevance to the field of pharmacology. (2) Commentaries. These are commissioned articles that provide the author's view on a selected topic of interest to pharmacologists.

Intended for life scientists involved in research of the interrelationships between chemistry, biochemistry, molecular and cellular biology. Covers a broad subject range, including topics such as enzymes, proteins, lipids, nucleic acids, genetics, viruses, immunochemistry, bioenergetics, membrane structure and function, and protein biosynthesis.